| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	
 
																	
 
																	Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target fro...
 
																	
 
																	Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target fro...
 
																	Morgan Stanley analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Overweight and raises the price target fro...
 
																	Risk sentiment deteriorated sharply on Wednesday as a wave of disappointing earnings guidance and escalating U.S.-China trade t...
 
																	BTIG analyst Marie Thibault reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains $132 price target.
 
																	Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results a...